EC Number   |
Natural Substrates |
|---|
    5.3.99.3 | (5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate |
- |
| 5.3.99.3 | (5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate |
PGH2 |
| 5.3.99.3 | (5Z,13E,15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate |
- |
| 5.3.99.3 | (5Z,13E,15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate |
reaction of heme-free isozyme mPGES2 |
| 5.3.99.3 | more |
platelet-derived growth factor-induced increase in enzyme activity occurs within min after exposure to the growth factor |
| 5.3.99.3 | more |
concordant induction of terminal prostaglandin E2 synthase with cyclooxygenase-2 leads to the preferred production of prostaglandin E2 over thromboxane B2 and prostaglandin D2, by lipopolysaccharide-stimulated macrophages |
| 5.3.99.3 | Prostaglandin H |
involved in prostaglandin synthesis, which in the case of prostaglandin E is likely to be associated with the subversion or suppression of host immunity |
| 5.3.99.3 | Prostaglandin H2 |
- |
| 5.3.99.3 | Prostaglandin H2 |
isozyme mPEGS-2 has an important role in urogenital function |
| 5.3.99.3 | Prostaglandin H2 |
mPGES-1 is a gonadotropin-regulated enzyme |
